Modulation of Gamma-Secretase for the Treatment of Alzheimer's Disease

International Journal of Alzheimer's Disease - United States
doi 10.1155/2012/210756
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Targeting the Β Secretase BACE1 for Alzheimer's Disease Therapy

The Lancet Neurology
Neurology
2014English

Modulation of Γ-Secretase Reduces Β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease

Neuron
Neuroscience
2010English

The Future of Alzheimer's Disease Treatment

Aging Health
2006English

G-Secretase/Presenilin Inhibitors for Alzheimer's Disease Phenocopy Notch Mutations in Drosophila

FASEB Journal
BiochemistryBiotechnologyGeneticsMolecular BiologyMedicine
2002English

Will Europe Be Ready for the Treatment of Alzheimer's Disease?

The Lancet Neurology
Neurology
2018English

Potential Repurposing of Oncology Drugs for the Treatment of Alzheimer's Disease

BMC Medicine
Medicine
2013English

Allosteric Modulation of the M1 Muscarinic Acetylcholine Receptor: Improving Cognition and a Potential Treatment for Schizophrenia and Alzheimer's Disease

Drug Discovery Today
Drug DiscoveryPharmacology
2013English

CD147 Is a Regulatory Subunit of the -Secretase Complex in Alzheimer's Disease Amyloid -Peptide Production

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Recent Tau-Targeted Clinical Strategies for the Treatment of Alzheimer's Disease

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy